Role of Chemokines in the Development and Progression of Alzheimer's Disease

J Wojcieszak, K Kuczyńska, JB Zawilska - Journal of Molecular …, 2022 - Springer
Alzheimer's disease (AD) is a progressive neurogenerative disorder manifested by gradual
memory loss and cognitive decline due to profound damage of cholinergic neurons. The …

On the role of paraoxonase-1 and chemokine ligand 2 (CC motif) in metabolic alterations linked to inflammation and disease. A 2021 update

J Camps, H Castañé, E Rodríguez-Tomàs… - Biomolecules, 2021 - mdpi.com
Infectious and many non-infectious diseases share common molecular mechanisms. Among
them, oxidative stress and the subsequent inflammatory reaction are of particular note …

A CCR5 antagonist, maraviroc, alleviates neural circuit dysfunction and behavioral disorders induced by prenatal valproate exposure

Y Ishihara, T Honda, N Ishihara, K Namba… - Journal of …, 2022 - Springer
Background Valproic acid (VPA) is a clinically used antiepileptic drug, but it is associated
with a significant risk of a low verbal intelligence quotient (IQ) score, attention-deficit …

Therapeutic Mechanism and Key Alkaloids of Uncaria rhynchophylla in Alzheimer's Disease From the Perspective of Pathophysiological Processes

P Zeng, HF Su, CY Ye, SW Qiu, Q Tian - Frontiers in Pharmacology, 2021 - frontiersin.org
Presently, there is a lack of effective disease-modifying drugs for the treatment of Alzheimer's
disease (AD). Uncaria rhynchophylla (UR) and its predominant active phytochemicals …

CCR5 regulates Aβ1-42-induced learning and memory deficits in mice

HY Huang, S Salinas, J Cornell, IB Udoh… - … of Learning and …, 2024 - Elsevier
Abstract C–C chemokine receptor 5 (CCR5) is a chemokine receptor involved in immune
responses and a co-receptor for HIV infection. Recently, CCR5 has also been reported to …

Cellular, synaptic, and network effects of chemokines in the central nervous system and their implications to behavior

JE Sowa, K Tokarski - Pharmacological Reports, 2021 - Springer
Accumulating evidence highlights chemokines as key mediators of the bidirectional
crosstalk between neurons and glial cells aimed at preserving brain functioning. The …

Identification of molecular signatures and candidate drugs in vascular dementia by bioinformatics analyses

J Shu, W Wei, L Zhang - Frontiers in Molecular Neuroscience, 2022 - frontiersin.org
Vascular dementia (VaD) is considered to be the second most common form of dementia
after Alzheimer's disease, and no specific drugs have been approved for VaD treatment. We …

CCR5 receptor occupancy analysis reveals increased peripheral blood CCR5+ CD4+ T cells following treatment with the anti-CCR5 antibody leronlimab

XL Chang, HL Wu, GM Webb, M Tiwary… - Frontiers in …, 2021 - frontiersin.org
CCR5 plays a central role in infectious disease, host defense, and cancer progression,
thereby making it an ideal target for therapeutic development. Notably, CCR5 is the major …

Targets and mechanisms of Alpinia oxyphylla Miquel fruits in treating neurodegenerative dementia

P Zeng, YC Liu, XM Wang, CY Ye, YW Sun… - Frontiers in Aging …, 2022 - frontiersin.org
The dried and ripe fruits of Alpinia oxyphylla and ripe fruits of Alpinia oxyphylla Miquel (AO)
have the effects of tonifying kidney-essence and nourishing intelligence and thus have been …

[HTML][HTML] 5-HT7R enhances neuroimmune resilience and alleviates meningitis by promoting CCR5 ubiquitination

Z Gao, Y Gao, Y Li, J Zhou, G Li, S Xie, R Jia… - Journal of Advanced …, 2024 - Elsevier
Introduction Excessive immune activation induces tissue damage during infection.
Compared to external strategies to reconstruct immune homeostasis, host balancing ways …